Bioequivalence and Bioavailability Forum

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log-in |  Register |  Search

Back to the forum  Query: 2017-11-24 14:02 CET (UTC+1h)
 

long half life drug bioequivalence study design [Design Issues]

posted by ElMaestro - Denmark, 2017-08-16 12:53  - Posting: # 17691
Views: 1,098

Hi ssussu,

» Should I just need to design the sampling time to 72hr or need to longer than 72hr?
» If I just sampling for 72hr, how can I prove the drug is a long half life drug?

In my humble opinion and experience:It is not much of a deal, actually.

I could be wrong, but…


Best regards,
ElMaestro

No, I still don't believe much in the usefulness of IVIVCs for OIPs when it comes to picking candidate formulations for the next trial. This is not the same as saying I don't believe in IVIVCs.

Complete thread:

Back to the forum Activity
 Mix view
Bioequivalence and Bioavailability Forum | Admin contact
17,495 Posts in 3,746 Threads, 1,085 registered users;
35 users online (1 registered, 34 guests).

The belief that there is only one truth and
that oneself is in possession of it,
seems to me the deepest root of all
that is evil in the world.    Max Born

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
XHTML/CSS RSS Feed